Everence Capital Management’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,760
| Closed | -$93K | – | 866 |
|
|
2024
Q3 | $93K | Buy |
16,760
+2,900
| +21% | +$16.1K | 0.01% | 745 |
|
|
2024
Q2 | $83 | Hold |
13,860
| – | – | 0.01% | 737 |
|
|
2024
Q1 | $93 | Hold |
13,860
| – | – | 0.01% | 754 |
|
|
2023
Q4 | $126K | Sell |
13,860
-2,160
| -13% | -$19.6K | 0.01% | 738 |
|
|
2023
Q3 | $88 | Buy |
+16,020
| New | +$88 | 0.01% | 738 |
|